Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Michael Lewiecki

Showing results (51-60 of 253) with videos related to

Pageof 26
Sort By:
Osteoporosis and Sarcopenia|September 9, 2020
Vitamin D and COVID-19: Is something better than nothing?E Michael Lewiecki
Obstetrics and Gynecology Clinics of North America|May 20, 2008
Prevention and treatment of postmenopausal osteoporosisE Michael Lewiecki
Current Osteoporosis Reports|April 24, 2008
Intravenous zoledronic acid for the treatment of osteoporosisE Michael Lewiecki
Therapeutic Advances in Musculoskeletal Disease|April 2, 2014
Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseasesE Michael Lewiecki
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 4, 2009
Evidence-based medicine, clinical practice guidelines, and common sense in the management of osteoporosisE Michael Lewiecki, Neil Binkley
Expert Opinion on Emerging Drugs|August 1, 2017
Emerging anabolic agents in the treatment of osteoporosisChristina Lovato, E Michael Lewiecki
Rheumatic Diseases Clinics of North America|April 7, 2019
Project ECHO: Telehealth to Expand Capacity to Deliver Best Practice Medical CareE Michael Lewiecki, Rachelle Rochelle
Current Osteoporosis Reports|June 23, 2012
Bone density testing intervals and common senseE Michael Lewiecki, Neil Binkley
Bone|December 22, 2016
DXA: 30years and counting: Introduction to the 30th anniversary issueE Michael Lewiecki, Neil Binkley
Expert Review of Clinical Pharmacology|March 4, 2014
Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapyMaryam Sharifi, E Michael Lewiecki
Pageof 26

Showing results (51-60 of 253) with videos related to

Sort By:
Pageof 26
Osteoporosis and Sarcopenia|September 9, 2020
Vitamin D and COVID-19: Is something better than nothing?E Michael Lewiecki
Obstetrics and Gynecology Clinics of North America|May 20, 2008
Prevention and treatment of postmenopausal osteoporosisE Michael Lewiecki
Current Osteoporosis Reports|April 24, 2008
Intravenous zoledronic acid for the treatment of osteoporosisE Michael Lewiecki
Therapeutic Advances in Musculoskeletal Disease|April 2, 2014
Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseasesE Michael Lewiecki
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 4, 2009
Evidence-based medicine, clinical practice guidelines, and common sense in the management of osteoporosisE Michael Lewiecki, Neil Binkley
Expert Opinion on Emerging Drugs|August 1, 2017
Emerging anabolic agents in the treatment of osteoporosisChristina Lovato, E Michael Lewiecki
Rheumatic Diseases Clinics of North America|April 7, 2019
Project ECHO: Telehealth to Expand Capacity to Deliver Best Practice Medical CareE Michael Lewiecki, Rachelle Rochelle
Current Osteoporosis Reports|June 23, 2012
Bone density testing intervals and common senseE Michael Lewiecki, Neil Binkley
Bone|December 22, 2016
DXA: 30years and counting: Introduction to the 30th anniversary issueE Michael Lewiecki, Neil Binkley
Expert Review of Clinical Pharmacology|March 4, 2014
Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapyMaryam Sharifi, E Michael Lewiecki
Pageof 26